*Mounjaro® is not a weight loss drug. Please note that due to the Mounjaro® shortage, specific dose strengths, particularly starter doses, may be unavailable. If Mounjaro® is commercially unavailable and listed on the FDA shortage list, our doctors may prescribe compounded tirzepatide, the active ingredient in Mounjaro®, if deemed appropriate. These compounded medications are prepared by our preferred state-licensed sterile compounding pharmacy partner that complies with all federal and state laws and FDA regulations. However, compounded tirzepatide, like all compounded drugs, is not FDA-approved and does not undergo FDA review for safety, effectiveness, or manufacturing. Compounded tirzepatide prescriptions are limited to residents in the following states: AZ, CA, CO, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SD, TN, TX, UT, VA, WA, WV, Washington D.C., WY. Prescriptions are provided at the doctor’s discretion.